Wellgistics Health, Inc.

Wellgistics Health, Inc.

WGRX·NASDAQ

$0.72

-7.8%
HealthcareMedical - Distribution

Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.

At a Glance

Live Snapshot
Market Cap$50.74M
EPS-0.1100
P/E Ratio-2.24
Earnings Date11/18/2025
wgrx

Wellgistics Health, Inc. Street Expectations Map

WGRX · NASDAQ

No Target Data

No analyst price targets available for wgrx.

wgrx

Wellgistics Health, Inc. Forward Estimates of Revenue

WGRX · NASDAQ
Latest Revenue
18.13M
FY 2024
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

wgrx

Wellgistics Health, Inc. Forward Estimates of Net Income

WGRX · NASDAQ
Latest Net Income
-6.86M
FY 2024
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

wgrx

Wellgistics Health, Inc. Forward Estimates of EPS

WGRX · NASDAQ
Latest EPS
-0.13
FY 2024
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

wgrx

Wellgistics Health, Inc. Forward Estimates of EBIT

WGRX · NASDAQ
Latest EBIT
-6.02M
FY 2024
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

wgrx

Wellgistics Health, Inc. Forward Estimates of EBITDA

WGRX · NASDAQ
Latest EBITDA
-4.91M
FY 2024
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

wgrx

Wellgistics Health, Inc. Forward Estimates of SG&A Expense

WGRX · NASDAQ
Latest SG&A Expense
6.80M
FY 2024
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

wgrx

Wellgistics Health, Inc. Insider Positioning

WGRX · NASDAQ

During the last 12 months, insiders have sold $180K worth of WGRX shares, with no buying activity reported.

3 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

3-6 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

6-9 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

9-12 Months

Bought

0

0.00

Sold

200.0K

180.00K

Net Activity

-180K

-$180K

Top Buyers

No buying activity

Top Sellers

1
PML

Peterson Michael L

Director

200.0K shares1 transactions

$180K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $180K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Insider Participation

High Selling

1 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.